OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
November 17, 2014
Grand River Aseptic Manufacturing has announced that the company executed two commercial production contracts in one day.
Avastin plus chemotherapy for the treatment of ovarian cancer increased progression-free survival by 62% compared with chemotherapy alone.
After being plagued by numerous delays, Lemtrada (alemtuzumab) has finally been approved by FDA for the treatment of multiple sclerosis.
November 15, 2014
Advanced analytical methods are speeding up the targeted evaluation of potential viral contaminants.
November 14, 2014
Carrying on from our weekly column to help you eliminate a number of tablet manufacturing problems and tablet tooling failures with a simple seven-step tool-care process, we look at the third step, Repair.
November 13, 2014
Catalent has acquired Micron Technologies, a provider of particle size engineering technologies.
November 10, 2014
As the second part of this series, we look at the importance of ?assessing? the punches and dies to check their condition and how this step may help avoid any problems that may occur during tablet manufacture.
November 06, 2014
Catalent Pharma Solutions announces additional packaging and storage space for highly potent and cytotocix drugs at Kansas City facility.
Capsugel gives lead users access to intrinsically enteric capsule technology and support services.
November 02, 2014
Manufacturers face regulatory overhaul, while brand-generic debates escalate over biosimilars and labeling changes.